This case-control study investigates the association between influenza vaccination and subsequent hospitalization for community-acquired influenza pneumonia.
This randomized trial compares the immunogenicity and safety of avian influenza A(H7N9) vaccines that differ by adjuvant type and dosing schedule.
This randomized trial reports point-of-use mixing and administration of 2 doses of H7N9 vaccine at the lowest tested antigen dose with MF59 adjuvant, producing seroconversion in participants.
Dr Udell and coauthors determine if influenza vaccination is associated with prevention of cardiovascular events from randomized clinical trials comparing influenza vaccine vs placebo or control in high-risk cardiovascular patients. In an Editorial, Neuzil discusses the trial limitations in establishing the level of protection of a vaccine from the perspective of public health and offers proven methods to increase vaccination coverage for the 2013-2014 influenza season.